Evaluating NAT2PRED for inferring the individual acetylation status from unphased genotype data
<p>Abstract</p> <p>Background</p> <p>Genetically determined differences in <it>N</it>-acetylation capacity have proved to be important determinants of both the effectiveness of therapeutic response and the development of adverse drug reactions and toxicity d...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2009-12-01
|
| Series: | BMC Medical Genetics |
| Online Access: | http://www.biomedcentral.com/1471-2350/10/148 |